Skip to main content

Advertisement

Log in

A Review of Laparoscopic Sleeve Gastrectomy for Morbid Obesity

  • Review
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Laparoscopic sleeve gastrectomy (LSG) is an innovative approach to the surgical management of morbid obesity. Weight loss may be achieved by restrictive and endocrine mechanisms. Early data suggest LSG is efficacious in the management of morbid obesity and may have an important role either as a staged or definitive procedure. A systematic review of the literature analyzing the clinical and operational outcomes of LSG was completed to further define the status of LSG as an emerging treatment modality for morbid obesity. Data from LSG were compared to benchmark clinical data and local operational data from laparoscopic adjustable gastric band (LAGB) and laparoscopic gastric bypass (LRYGB). Fifteen studies (940 patients) were identified following systematic review. The percent excessive weight loss (%EWL) for LSG varied from 33% to 90% and appeared to be sustained up to 3 years. The mortality rate was 0-3.3% and major complications ranged from 0% to 29% (average 12.1%). Operative time ranged from 49 to 143 min (average 100.4 min). Hospital stay varied from 1.9 to 8 days (average 4.4 days). The operational impact of LSG has not been described in the literature. According to data from the Royal Alexandra Hospital, the estimated total cost of LSG was $10,317 CAD as compared to LAGB ($7,536 CAD) and LRYGB ($11,666 CAD). These costs did not include further surgical interventions which may be required for an undefined group of patients after LSG. Early, non-randomized data suggest that LSG is efficacious in the surgical management of morbid obesity. However, it is not clear if weight loss following LSG is sustainable in the long term and therefore it is not possible to determine what percent of patients may require further revisional surgery following LSG. The operational impact of LSG as a staged or definitive procedure is poorly defined and must be analyzed further in order to establish its overall health care costs and operational impact. Although LSG is a promising treatment option for patients with morbid obesity, its role remains undefined and it should be considered an investigational procedure that may require revision in a subset of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chronic disease information sheets [database on the Internet]. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/. Accessed 9 June 2009.

  2. The International Classification of adult underweight, overweight and obesity according to BMI. Global database 2004. Accessed 28 Apr 2009.

  3. Tjepkema M. Adult obesity. Health Rep. 2006;17(3):9–25.

    PubMed  Google Scholar 

  4. IARC. Internation Agency for Research on Cancer: Food, nutrition, physical activity and the prevention of cancer: a global perspective. 2005 [updated 2005; cited]. http://www.dietandcancerreport.org/. Accessed 9 June 2009.

  5. Calle EE, Rodriguez C, Walker-Thurmond K. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–38.

    Article  PubMed  Google Scholar 

  6. Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev. 2006;7(4):333–40.

    Article  CAS  PubMed  Google Scholar 

  7. Gong Z, Agalliu I, Lin DW. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 2007;109(6):1192–202.

    Article  PubMed  Google Scholar 

  8. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50. discussion 50-2.

    Article  CAS  PubMed  Google Scholar 

  9. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.

    Google Scholar 

  10. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234(3):279–89. discussion 89-91.

    Article  CAS  PubMed  Google Scholar 

  11. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third party payers. Surg Obes Relat Dis. 2005;1(3):371–81.

    Article  PubMed  Google Scholar 

  12. Frezza EE. Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice? Surg Today. 2007;37(4):275–81.

    Article  PubMed  Google Scholar 

  13. Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15(7):1024–9.

    Article  CAS  PubMed  Google Scholar 

  14. Arias E, Martinez PR, Ka Ming Li V. Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg. 2009;19(5):544–8.

    Article  PubMed  Google Scholar 

  15. Nocca D, Krawczykowsky D, Bomans B, et al. A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg. 2008;18(5):560–5.

    Article  CAS  PubMed  Google Scholar 

  16. Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy: a restrictive procedure? Obes Surg. 2007;17(1):57–62.

    Article  PubMed  Google Scholar 

  17. Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21(10):1810–6.

    Article  PubMed  Google Scholar 

  18. Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16(9):1138–44.

    Article  PubMed  Google Scholar 

  19. Roa PE, Kaidar-Person O, Pinto D. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16(10):1323–6.

    Article  PubMed  Google Scholar 

  20. Langer FB, Bohdjalian A, Felberbauer FX, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16(2):166–71.

    Article  PubMed  Google Scholar 

  21. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16(11):1450–6.

    Article  PubMed  Google Scholar 

  22. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20(6):859–63.

    Article  CAS  PubMed  Google Scholar 

  23. Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15(10):1469–75.

    Article  PubMed  Google Scholar 

  24. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15(7):1030–3.

    Article  PubMed  Google Scholar 

  25. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first-stage procedure for super-obese patients (BMI ≥50). Obes Surg. 2005;15(5):612–7.

    Article  PubMed  Google Scholar 

  26. Baltasar A, Serra C, Perez N. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15(8):1124–8.

    Article  PubMed  Google Scholar 

  27. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14(4):492–7.

    Article  PubMed  Google Scholar 

  28. Regan JP, Inabnet WB, Gagner M. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13(6):861–4.

    Article  CAS  PubMed  Google Scholar 

  29. Laparoscopic adjustable gastric banding for weight loss in obese adults: clinical and economic review. Canadian Agency for Drugs and Technologies in Health 2007. http://www.cadth.ca/media/pdf/L3009_LAGB_tr_e.pdf. Accessed April 2009

  30. Tice JA, Karliner L, Walsh J. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–93.

    Article  PubMed  Google Scholar 

  31. Luo W, Morrison H, de Groh M, et al. The burden of adult obesity in Canada. Chronic Dis Can. 2007;27(4):135–44.

    PubMed  Google Scholar 

  32. Measured obesity: overweight Canadian children and adolescents. Statistics Canada 2005. www.statcan.ca/english/research/82-620-MIE/2005001/pdf/cobesity.pdf. Accessed April 2009

  33. Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol. 2004;29(1):90–115.

    PubMed  Google Scholar 

Download references

Conflict of interest disclosure

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinzhe Shi.

Appendices

Appendix 1

Table 4 Summary of included studies

Appendix 2

Table 5 The improvements of comorbidities after LSG

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, X., Karmali, S., Sharma, A.M. et al. A Review of Laparoscopic Sleeve Gastrectomy for Morbid Obesity. OBES SURG 20, 1171–1177 (2010). https://doi.org/10.1007/s11695-010-0145-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-010-0145-8

Keywords

Navigation